New drugs added to palliative care listNew drugs added to palliative care list

Published 2006-08-01 00:00:00

The following drugs have been included in the Palliative Care section of the Schedule of Pharmaceutical Benefits for patients ineligible to have these medications subsidised via the current PBS listings:

  • Benzydamine hydrochloride mouth and throat rinse (Difflam)
  • Lactulose mixture (various brands) and Macrogol 3350 (Movicol) for constipation
  • Naproxen 125 mg/5 mL oral suspension (Naprosyn)
  • Morphine sulfate immediate-release tablets 10 mg, 20 mg (Sevredol)
  • Morphine sulfate controlled-release tablets 200 mg (MS Contin).

Prescribers are reminded that prescribing opioids must be in accordance with the requirements of State or Territory legislation.

As with all medicines in the palliative care list, quantities for continued supply exceeding one month are allowed only after consultation with a palliative care specialist or service.

For full details of brand names, forms, strengths, and conditions of use, refer to the Schedule.

RSS FeedRSS feed

Date published: 2006-08-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.